Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2024-05-02 Share Issue/Capital Cha…
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - 4DX 9 pages 22.5KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and details the application for quotation of securities issued under an employee incentive scheme by 4DMedical Limited. It includes specifics about the securities, issue dates, and compliance with ASX Listing Rules. There is no financial performance data, earnings information, or management discussion. The document is a formal announcement related to the quotation of new securities on the exchange, which aligns with announcements about share issues or capital changes. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length (7173 characters) and content confirm it is the actual announcement, not just a brief notice or report publication announcement.
2024-05-02 English
Quarterly Activity Report and Appendix 4C for Q3 FY2024 11 pages 534.2KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activity Report and Appendix 4C for Q3 FY2024' and dated 30 April 2024. It contains detailed financial performance data for the quarter ended 31 March 2024, including operating revenue, cash balances, and net cash operating outflows. It also discusses operational activities, commercialisation progress, and strategic agreements during the quarter. The presence of Appendix 4C (a cash flow report format used in Australian ASX announcements) and the detailed quarterly financial and operational data indicate this is a comprehensive interim/quarterly report rather than a brief announcement or presentation. The document length (15,000 characters) and substantive financial and operational content confirm it is a full quarterly report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2024
2024-04-29 English
Notification regarding unquoted securities - 4DX 8 pages 21.1KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and contains detailed information about the issuance of unquoted securities under an employee incentive scheme by 4DMedical Limited. It includes specifics such as the number of securities issued, dates, security codes, and references to ASX listing rules. The content focuses on the issuance of securities and capital changes rather than financial performance, management changes, or regulatory compliance. The document length is 7285 characters, which is substantive and contains detailed data about the securities issued. This matches the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues or other capital changes.
2024-04-18 English
Application for quotation of securities - 4DX 9 pages 22.6KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX announcement for the application for quotation of securities. It details the issuance and quotation of securities under an employee incentive scheme, including the number of securities, issue date, and other listing rule requirements. There are no financial statements, management discussion, or earnings data. The document is regulatory in nature, announcing a capital market action related to securities quotation. This fits the category of Share Issue/Capital Change (SHA), as it concerns the issuance and quotation of new shares under an employee incentive scheme.
2024-04-18 English
Application for quotation of securities - 4DX 9 pages 22.5KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement from 4DMedical Limited regarding the application for quotation of securities issued under an employee incentive scheme. It details the number and type of securities to be quoted, issue dates, and compliance with ASX Listing Rules. The content is focused on the application and announcement of new securities to be quoted on the exchange, not a financial report or earnings release. This matches the description of a Share Issue/Capital Change announcement, which covers new share issues or capital changes. The document length is 8101 characters, which is substantive and contains detailed information about the securities issuance and quotation application, not just a brief notice or link to a report. Therefore, the correct classification is Share Issue/Capital Change (SHA).
2024-04-04 English
Notification regarding unquoted securities - 4DX 11 pages 31.0KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and contains detailed information about the issuance of unquoted securities, including options and performance rights, under an employee incentive scheme. It includes specifics such as security codes, issue dates, number of securities issued, and mentions key management personnel involved. The document is a formal notification to the ASX (Australian Securities Exchange) about securities issuance. This type of document is a regulatory announcement about capital changes, specifically the issuance of new securities. It is not a full financial report, earnings release, or management discussion. It is not a report publication announcement or certification. The content fits the category of Share Issue/Capital Change (SHA) as it details new share issues and related securities changes.
2024-03-19 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.